Teruo Murakami

4.0k total citations
135 papers, 3.2k citations indexed

About

Teruo Murakami is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Teruo Murakami has authored 135 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 35 papers in Pediatrics, Perinatology and Child Health and 28 papers in Molecular Biology. Recurrent topics in Teruo Murakami's work include Drug Transport and Resistance Mechanisms (52 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Drug Solubulity and Delivery Systems (14 papers). Teruo Murakami is often cited by papers focused on Drug Transport and Resistance Mechanisms (52 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Drug Solubulity and Delivery Systems (14 papers). Teruo Murakami collaborates with scholars based in Japan, United States and Italy. Teruo Murakami's co-authors include Mikihisa Takano, Ryoko Yumoto, Junya Nagai, Noboru Yata, Yutaka Higashi, Takashi Sugita, Tomoharu Yokooji, Yoshikazu Ikuta, Nobuhiro Mori and Tadahiko Kubo and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Controlled Release and Kidney International.

In The Last Decade

Teruo Murakami

134 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teruo Murakami Japan 30 1.2k 817 714 588 508 135 3.2k
Jeffrey A. Silverman United States 35 2.0k 1.6× 1.1k 1.4× 856 1.2× 619 1.1× 335 0.7× 93 3.8k
Mikihisa Takano Japan 37 2.1k 1.7× 1.6k 1.9× 1.1k 1.6× 688 1.2× 414 0.8× 185 4.9k
Ismael J. Hidalgo United States 29 2.3k 1.8× 1.8k 2.2× 783 1.1× 595 1.0× 919 1.8× 70 5.6k
Johan Karlsson Sweden 29 1.6k 1.3× 1.6k 1.9× 573 0.8× 438 0.7× 817 1.6× 50 4.6k
Reza Mehvar United States 28 653 0.5× 766 0.9× 237 0.3× 732 1.2× 245 0.5× 143 3.4k
Ashim K. Mitra United States 41 1.2k 1.0× 1.5k 1.8× 573 0.8× 379 0.6× 1.0k 2.1× 144 4.6k
Ryoko Yumoto Japan 25 887 0.7× 654 0.8× 475 0.7× 361 0.6× 303 0.6× 96 2.3k
Junya Nagai Japan 28 881 0.7× 824 1.0× 530 0.7× 419 0.7× 195 0.4× 88 2.6k
Saeho Chong United States 29 795 0.6× 953 1.2× 267 0.4× 341 0.6× 829 1.6× 68 3.0k
Masato Yasuhara Japan 28 898 0.7× 1.0k 1.2× 620 0.9× 303 0.5× 127 0.3× 126 3.5k

Countries citing papers authored by Teruo Murakami

Since Specialization
Citations

This map shows the geographic impact of Teruo Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruo Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruo Murakami more than expected).

Fields of papers citing papers by Teruo Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teruo Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruo Murakami. The network helps show where Teruo Murakami may publish in the future.

Co-authorship network of co-authors of Teruo Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Teruo Murakami. A scholar is included among the top collaborators of Teruo Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teruo Murakami. Teruo Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Teruo, et al.. (2024). Pharmacotherapy for Keloids and Hypertrophic Scars. International Journal of Molecular Sciences. 25(9). 4674–4674. 18 indexed citations
2.
Maeda, Yorinobu & Teruo Murakami. (2023). Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth. Antibiotics. 12(2). 263–263. 13 indexed citations
3.
4.
Mori, Nobuhiro, Keisuke Oda, Hideki Takakura, et al.. (2023). Comparison of Berberine Bioavailability between Oral and Rectal Administrations in Rats. Biological and Pharmaceutical Bulletin. 46(11). 1639–1642. 4 indexed citations
5.
Mori, Nobuhiro, et al.. (2012). Comparison of In Vivo with In Vitro Pharmacokinetics of Mercury Between Methylmercury Chloride and Methylmercury Cysteine Using Rats and Caco2 Cells. Archives of Environmental Contamination and Toxicology. 63(4). 628–636. 13 indexed citations
6.
7.
Daodee, Supawadee, et al.. (2007). Membrane Transport of Andrographolide in Artificial Membrane and Rat Small Intestine. Pakistan Journal of Biological Sciences. 10(12). 2078–2085. 8 indexed citations
8.
Maeda, Yorinobu, et al.. (2006). Evaluation of Clinical Efficacy of Maeda’s Nomogram for Vancomycin Dosage Adjustment in Adult Japanese MRSA Pneumonia Patients. Drug Metabolism and Pharmacokinetics. 21(1). 54–60. 9 indexed citations
9.
Murakami, Teruo, et al.. (2005). Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. Journal of Pharmaceutical Sciences. 94(8). 1685–1693. 26 indexed citations
10.
Maeda, Yorinobu, Takashi Moriya, Akira Maruhashi, et al.. (2004). Employing Renal Function in Determining Ribavirin Dosages for Chronic Hepatitis C Patients to Help Ensure Safer Treatment. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30(9). 567–573. 1 indexed citations
11.
Yumoto, Ryoko, Teruo Murakami, & Mikihisa Takano. (2003). Differential Effect of Acute Hepatic Failure on in Vivo and in Vitro P-Glycoprotein Functions in the Intestine. Pharmaceutical Research. 20(5). 765–771. 19 indexed citations
12.
Murakami, Teruo, et al.. (2002). Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states.. PubMed. 57(2). 102–7. 24 indexed citations
13.
Takano, Mikihisa, et al.. (2002). Cisplatin-induced inhibition of receptor-mediated endocytosis of protein in the kidney. Kidney International. 62(5). 1707–1717. 34 indexed citations
14.
Huang, Zhaohui, et al.. (2000). Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. European Journal of Pharmacology. 406(3). 453–460. 70 indexed citations
15.
Hatta, Tatsuo, Hiromitsu Ohmori, Teruo Murakami, et al.. (1999). Neurotoxic Effects of Phenytoin on Postnatal Mouse Brain Development Following Neonatal Administration. Neurotoxicology and Teratology. 21(1). 21–28. 27 indexed citations
16.
Harada, Shinichi, Teruo Murakami, Yutaka Higashi, Mikihisa Takano, & Noboru Yata. (1997). Enhancing Mechanisms of Decanoic Acid for the Permeation of Water-soluble Compounds through Caco-2 Cell Monolayers. Pharmacy and Pharmacology Communications. 3(4). 175–178. 2 indexed citations
17.
Ikuta, Yoshikazu, et al.. (1997). The present clinical therapy for keloids and hypertrophic scars and experience of iontophoretic therapy with tranilast.. Drug Delivery System. 12(2). 115–120. 1 indexed citations
18.
Murakami, Teruo, et al.. (1996). Transdermal Iontophoretic Delivery of Triamcinolone Agetonide: A Preliminary Study in Hairless Rats. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 30(3). 177–181. 6 indexed citations
19.
Murakami, Teruo & Noboru Yata. (1995). Controlled drug release by the use of porous calcium silicete.. Drug Delivery System. 10(3). 159–166. 3 indexed citations
20.
Higashi, Yutaka, et al.. (1983). A POSSIBLE MECHANISM OF ABSORPTION PROMOTERS. Journal of Pharmacobio-Dynamics. 6(4). 78. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Silverman Breakdown of academic impact, for papers by Mikihisa Takano Breakdown of academic impact, for papers by Ismael J. Hidalgo Breakdown of academic impact, for papers by Johan Karlsson Breakdown of academic impact, for papers by Reza Mehvar Breakdown of academic impact, for papers by Ashim K. Mitra Breakdown of academic impact, for papers by Ryoko Yumoto Breakdown of academic impact, for papers by Junya Nagai Breakdown of academic impact, for papers by Saeho Chong Breakdown of academic impact, for papers by Masato Yasuhara
Rankless by CCL
2026